Hayden Michael R

Average Profitability
38.35%
Insider Buys Quantity
13
Insider Buys Sum
$5.33M
Insider Sells Quantity
1
Insider Sells Sum
$2.55M

Insider Activity of Hayden Michael R

According to the SEC Form 4 filings, Hayden Michael R, being in a position of

  1. director at Ionis Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 5000 shares for $181,079, and sold 0 shares,
    over all time since 2024-12-23, has bought 5000 shares for $181,079, and sold 0 shares.

The largest purchase of all time was on 2020-12-15 and amounted to 147330 shares of AbCellera Biologics Inc. for $2.95M.

The largest sale of all time was on 2021-06-22 and amounted to 100000 shares of AbCellera Biologics Inc. for $2.55M.

Biography of Hayden Michael R

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $181,0791100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2024-12-23PurchaseIonis Pharmaceuticals, Inc.
IONS
director
5,000
0.0032%
$36.22$181,079-8.68%
2023-09-22PurchaseAbCellera Biologics Inc.
ABCL
director
20,000
0.0066%
$4.91$98,200-14.3%
2023-08-08PurchaseAbCellera Biologics Inc.
ABCL
director
30,000
0.0104%
$5.90$177,000-23.77%
2023-03-28Purchase89bio, Inc.
ETNB
director
61,538
0.112%
$16.15$993,839-10.96%
2022-04-25Purchase89bio, Inc.
ETNB
director
10,000
0.0475%
$2.67$26,700+196.74%
2022-04-25Purchase89bio, Inc.
ETNB
director
20,000
0.0951%
$2.67$53,400+196.74%
2022-04-07Purchase89bio, Inc.
ETNB
director
10,000
0.0496%
$3.48$34,750+120.78%
2022-04-07Purchase89bio, Inc.
ETNB
director
20,000
0.0993%
$3.48$69,500+120.78%
2022-03-30Purchase89bio, Inc.
ETNB
director
6,250
0.0309%
$3.62$22,625+74.44%
2022-03-30Purchase89bio, Inc.
ETNB
director
12,500
0.0618%
$3.62$45,250+74.44%
2021-06-22SaleAbCellera Biologics Inc.
ABCL
director
100,000
0.0424%
$25.50$2.55M-36.66%
2020-12-15PurchaseAbCellera Biologics Inc.
ABCL
director
147,330
0.0394%
$20.00$2.95M-51.21%
2019-11-11Purchase89bio, Inc.
ETNB
director
37,500
1.2305%
$16.00$600,000+28.8%
2017-08-14PurchaseXenon Pharmaceuticals Inc.
XENE
director
30,000
0.1833%
$2.75$82,494+44.6%
Total: 14
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.